Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers

Infection Control and Hospital Epidemiology

Volumn 30, Issue 6, 2009, Pages 600-603

  Pakyz, Amy L ^a   Gurgle, Holly E ^a   Ibrahim, Omar M ^a   Oinonen, Michael J ^b   Polk, Ronald E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b University HealthSystem Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BENZATHINE PENICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DICLOXACILLIN; DOXYCYCLINE; LINCOSAMIDE DERIVATIVE; LINEZOLID; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; NAFCILLIN; OXACILLIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN G POTASSIUM; PENICILLIN G SODIUM; PENICILLIN V POTASSIUM; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE DERIVATIVE; SULFANILAMIDE DERIVATIVE; TETRACYCLINE DERIVATIVE; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ARTICLE; CHILD; CLINICAL ASSESSMENT; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; PEDIATRICS; TREND STUDY; UNITED STATES; UNIVERSITY HOSPITAL; WORLD HEALTH ORGANIZATION;

ACADEMIC MEDICAL CENTERS; ACETAMIDES; ADOLESCENT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MACROLIDES; OXAZOLIDINONES; PEDIATRICS; UNITED STATES;

EID: 67651083557     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/597545     Document Type: Article

References (10)

1. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 2002; 287:3096-3102.
2. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA 2005; 294:2315-2322.
3. Stille CJ, Andrade SE, Huang SS, et al. Increased use of second-generation macrolide antibacterials for children in nine health plans in the United States. Pediatrics 2004; 114:1206-1211.
4. McCaig LF, Besser RE, Hughes JM. Antimicrobial drug prescriptions in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis 2003; 9:432-437.
5. Mainous AG III, Hueston WJ, Davis MP, Pearson WS. Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health 2003; 93:1910-1914.
6. Pakyz AL, MacDougall C., Oinonen M, Polk RE. Trends in antibacterial use in US academic health centers. Arch Intern Med 2008; 168:2254-2260.
7. World Health Organization (WHO). Collaborating Centre for Drug Statistics methodology: ATC index with DDDs. Oslo, Norway: WHO, 2004. Available at: http://www.whocc.no/atcddd/. Accessed January 6, 2009.
8. Grohskopf LA, Huskins WC., Sinkowitz-Cochran RL, Levine GL, Goldmann DA, Jarvis WR; the Pediatric Prevention Network. Use of anti microbial agents in United States neonatal intensive care patients. Pediatr Infect Dis J 2005; 24:766-773.
9. Scheetz MH, Knechtel SA, Malczynski M, Postelnick MJ, Qi C. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption. Antimicrob Agents Chemother 2008; 52:2256-2259.
10. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Managementof multidrug-resistant organisms in healthcare settings, 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ ar/mdroGuideline2006.pdf. Accessed January 24, 2009.